interim budget 2024: Budget 2024: Pharma industry seeks incentives for R&D, conducive policies
The pharma industry has sought fiscal incentives to promote research and development (R&D) in the sector, as it is likely to reach USD 400-450 billion...
Taking a break from social media is now fashionably called dopamine detox
Like any medical practitioner, Manoj Sharma sees a reasonable number of patients who sound like they have researched their symptoms online before approaching him. “Roughly...
cervical cancer: Govt says yet to take decision on roll-out of HPV vaccination against cervical cancer
The Union Health Ministry on Saturday said it is yet to take a decision on the roll-out of HPV vaccination against cervical cancer in the...
Central drug regulator cracks down on FDCs
In a move to regularise fixed-dose combinations (FDCs), India's drug regulator has directed manufacturers who received state licences before October 2012 to seek the central...
Breakthroughs in Reproductive Medicine Transforming IVF Success Rates
In recent times, the prevalence of infertility has surged, affecting one in every six couples, as reported by The World Health Organization. This growing challenge...
Healthium Medtech: Apax initiates sale of Healthium Medtech
The British Private equity firm Apax Partners has started the process to sell Healthium Medtech, the largest homegrown surgical sutures manufacturer, said multiple people aware...
Beat Diabetes With Lifestyle Modification – The Economic Times Video
The dreaded ‘D’ word—diabetes—no longer carries the same weight as a life sentence. While traditional diabetes management relied solely on medications, there’s a growing emphasis...
Ozone Pharmaceuticals eyes Rs 1,000 crore topline in next 3 years
Ozone Pharmaceuticals on Wednesday said it is eying a Rs 1,000 crore turnover in the next three years and has launched the 'Molecule initiative' with...
Indian pharma market grows over 9 per cent in December
NEW DELHI: The Indian pharmaceutical market has shown robust value growth of 9.2% with major therapies recording a double-digit increase in December.Among the top therapies,...
pharmaceutical companies: Government orders new drug-making standards after overseas deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a Union Health Ministry notification released on Saturday, although small companies have asked...
Three viruses behind Covid-like symptoms, testing key: Doctors
New Delhi: It's not just Covid that's on the rise but also cases of respiratory syncytial virus (RSV) and seasonal flu at this time of...
biotechnology: India is emerging as world leader in biotechnology: Union Minister Jitendra Singh
Jammu, Union Minister Jitendra Singh on Thursday said while the nation is emerging as a world leader in biotechnology, Kathua with north India's first biotech...
NephroPlus sale: Quadria in talks to buy into dialysis chain NephroPlus
Quadria Capital, the Asia healthcare-focused private equity fund, is in advanced talks to acquire a significant minority stake in India's largest dialysis chain NephroPlus, valuing...
Benefits of Mediterranean Diet during pregnancy, as per study
According to research published in The European Society of Human Reproduction and Embryology, women undergoing IVF should adopt a Mediterranean diet to improve their chances...
CMSS condoms order: Central procurement agency orders 350 million Nirodh condoms after negotiations held last month
After much dilly-dallying, the country's central procurement agency, the Central Medical Services Society (CMSS), set up to streamline the procurement process, has awarded tenders to...
Glenmark Pharmaceuticals: Glenmark launches antidiabetic drug in India
Glenmark Pharmaceuticals on Wednesday said it has launched a biosimilar of the popular antidiabetic drug, Liraglutide in India. The drug is being marketed under the...
hair straightening cancer: Hair straightening can give you cancer. Read doctors warning
While having straightened hair may boost your confidence, using chemicals repeatedly on your hair can have severe health consequences, potentially leading to cancer. The US...
IIL begins construction of Rs 700 crore facility to make FMD vaccines
Indian Immunologicals Ltd (IIL), a subsidiary of the National Dairy Development Board (NDDB) on Thursday said it has started construction of its new greenfield veterinary...
Covid JN.1 in Delhi: Guidelines from AIIMS
In response to the unexpected spike in coronavirus cases across the nation, the All India Institute of Medical Sciences (AIIMS) in Delhi has released guidelines...
A year of tech-enabled care and compassion: Sangita Reddy, Apollo Hospitals
2024 will be about tech-enabled care and compassion. We stand at the threshold of a transformative era in healthcare as we navigate the challenges and...
Focus shifts to healthcare delivery in 2023 as Covid stress eases
After three long years of Covid-induced turbulence, 2023 saw a semblance of normalcy in the health sector, allowing the government to turn its attention to...
benzodiazepine use: Benzodiazepine use linked with increased miscarriage risk, says new study
Use of benzodiazepine, a widely used drug to treat anxiety and insomnia, during pregnancy is associated with a higher risk of miscarriage, according to a...
Healthtech company Qure.ai to hit fund trail
Qure.ai, a Mumbai-based healthtech firm that uses artificial intelligence (AI) for medical imaging diagnostics, is gearing up for a large fundraise early next year to...
Investments worth Rs 25,813 crore made under pharma PLI as of Sept 2023: Govt
New Delhi, Investments worth Rs 25,813 crore have been made and 56,171 new jobs were added as of September this year under the production-linked incentive...
India’s pharma lobby bats for drug approvals in line with global markets
New Delhi: The Organisation of Pharmaceutical Producers of India (OPPI), which represents prominent multinational pharma companies, has urged the drug controller to enable parallel approval...
OmniActive scouts for acquisitions to expand product portfolio, reach
OmniActive Health Technologies, an integrated nutraceutical ingredient maker, is scouting for acquisitions to enlarge its product basket, gain access to customers and technologies, and expand...
Aurobindo Pharma gets USFDA nod for generic antifungal injection
Aurobindo Pharma Ltd on Wednesday said its wholly-owned arm Eugia Pharma Specialities Ltd has received final approval from the US health regulator to manufacture and...
Northeast: NEIAFMR to be developed as the national hub for folk medicine
Union Minister of Ayush Sarbananda Sonowal and the Chief Minister of Arunachal Prades, Pema Khandu laid the foundation stones for capacity expansion at the Northeastern...
Zydus Lifesciences: Zydus Lifesciences arm gets Rs 284.58 cr income tax demand notice
Zydus Lifesciences on Tuesday said its arm Zydus Healthcare Ltd has been served an income tax notice demand of Rs 284.58 crore for for the...
Swedish medtech company Elekta sees smaller cities driving growth
MUMBAI: Elekta, the Swedish medtech company that makes radiation therapy equipment for treating cancers and neurological disorders, is betting big on India. The company sees...
Smit.fit merges with Droobi Health to form new entity DroobiSmit
The digital health company, Smit.fit, has announced that it has merged with a digital diabetes player based in Doha, Qatar, resulting in the establishment of...
Union Minister Sarbananda Sonowal assures Rs 200 cr investment for CSIR-NEIST in Jorhat to boost medicinal plant market of northeast India
Guwahati: The Union Minister of Ports, Shipping & Waterways and Ayush, Sarbananda Sonowal visited CSIR-North East Institute of Science & Technology (CSIR-NEIST).The Minister assured complete...
Dengue to new strain of Covid: Diseases that made headlines in 2023
Amidst all this, a new strain of Covid called JN.1 created panic as cases jumped in Singapore. India is being affected too at the moment.
Cough syrup deaths: Maiden Pharma denies tampering with tests in probe of cough syrup deaths
India's Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples...
Intas in pact with Spanish drug maker mAbxience to sell biosimilar etanercept in over 150 countries
Intas Pharmaceuticals on Friday said it has entered into a licensing agreement with Spanish biopharma company mAbxience for marketing and distribution of the latter's biosimilar...
Covid JN.1 variant just like a winter flu: Viren Prasad Shetty of Narayana Health
Covid JN.1 variant just like a winter flu: Viren Prasad Shetty of Narayana Health
Steady rise in number of Covid-19 cases: Government not considering travel curbs, mask mandates for now
New Delhi: The government has no plans for travel restrictions, mask mandates, or even recommendations for booster shots despite a steady rise in the number...
covid jn.1: Is new Covid variant JN.1 shifting target from lungs to intestines? Here is the latest buzz among scientists
Scientists are raising concerns about the possibility of the JN.1 variant of Covid-19 specifically targeting the intestinal tracts of individuals. While the evidence is limited...
Govt bans anti-cold fixed drug combination for under-four children New Delhi
The Central Drugs Standard Control Organisation (CDSCO) has prohibited the use of anti-cold fixed drug combination in children below four years of age. Drugs Controller...
JB Pharma acquires trademark licenses, distribution rights of Novartis eye care portfolio in India for Rs 1089 crore
JB Chemicals & Pharmaceuticals (JB Pharma) on Tuesday said it has entered into trademark licensing agreement along with distribution and promotion of a portfolio of...
API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscent
Fleming Laboratories, a Hyderabad based active pharmaceutical ingredients (API) maker has raised Rs110 crore (approx. $13.23 million) from private equity investor InvAscent, through India Life...
meerut: ET Awards for Corporate Excellence: Rx Meerut: Mankind Pharma’s bottom-up journey to the leader board
Ramesh C Juneja, 68, and Rajeev Juneja, 58, cofounded Mankind Pharma, the fourth-largest pharmaceutical company in the domestic market, in 1991. Since then, they have...
Sun Pharma, Lupin recall drugs in US market: USFDA
New Delhi, Leading drugmakers Sun Pharma and Lupin are recalling products in the US market over manufacturing issues, as per the US Food and Drug...
